atrial fibrillation

By Jonah Comstock April 11, 2016
AliveCor is continuing to build up the clinical evidence for the efficacy of its smartphone-connected Kardia ECG devices. According to a new posting on ClinicalTrials.gov, AliveCor is gearing up to launch a 300-patient randomized trial at Columbia University to test the effect of technology-enabled remote monitoring on atrial fibrillation. "Atrial fibrillation (AF), a condition where the top...
By Jonah Comstock April 11, 2016
Doctors at an emergency room in New Jersey used data from a patient's Fitbit activity tracker -- which they happened to notice on his wrist -- to determine his course of treatment. When the 42-year-old patient showed up in the ER at Our Lady of Lourdes Medical Center in Camden, New Jersey, he had already had a seizure and he had atrial fibrillation. Doctors had to decide whether or not to use an...
By Jonah Comstock November 30, 2015
The Scripps Translational Science Institute is working with Aetna and Johnson & Johnson to launch a trial that will test iRhythm's Zio Patch and the Amiigo activity tracker as possible new ways to screen at-risk populations for atrial fibrillation. "What we really want at the end of this study is to be able to best understand what the right way is to screen high-risk patients for atrial...
By Jonah Comstock September 10, 2015
It's been almost a year since AliveCor began offering its first FDA-cleared algorithm, its atrial fibrillation detection algorithm, to customers. Now the company has released some data on how customers are using the algorithm to detect atrial fibrillation. According to AliveCor, 30 percent of AliveCor users have received a diagnosis of atrial fibrillation through the algorithm. More than half of...
By Jonah Comstock January 29, 2015
AliveCor's AF detection algorithm San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on AliveCor's atrial fibrillation detection algorithm that received clearance last fall. The Normal Detector assures patients that their ECG is free of abnormalities. If...
By Jonah Comstock January 13, 2015
Dr. Joseph Kvedar Partners HealthCare's Center for Connected Health is in the midst of a transition from being a technology group that supports care offerings to being an integrated connected care group within the hospital, according to a year-end blog post by (now Vice President of Connected Health) Dr. Joseph Kvedar. Kvedar sees the move as reflective as a larger trend in the connected care...
By Jonah Comstock January 7, 2015
Smartphone ECG company AliveCor announced the publication of a long-awaited independent trial of the technology conducted by the Cleveland Clinic. As was reported at Heart Rhythm Society in May 2014, the trial showed that AliveCor's heart monitor detected atrial fibrillation that was present 100 percent of the time, and only returned false positives 3 percent of the time. Researchers at the...
By Jonah Comstock September 29, 2014
Smartphone-enabled heart monitor device maker AliveCor has launched a new app for patients, which is both timed with the new iOS 8 launch and incorporates the atrial fibrillation algorithm the company received FDA clearance for in August. In addition to the AF algorithm, the new app allows patients to track medications and symptoms and has enhanced search features and graphic capabilities,...
By Jonah Comstock August 21, 2014
AliveCor has received an additional FDA 510(k) clearance, this time for an algorithm that allows its smartphone ECG to detect atrial fibrillation -- an abnormal heart rhythm that isn't always detectable to the patient, but if left untreated can lead to stroke or congestive heart failure -- with high accuracy. The app is set to launch for consumers in September. "Our pretty strong belief is that...
By Brian Dolan February 11, 2014
San Francisco-based AliveCor announced that the FDA has granted its smartphone-enabled, single-channel ECG (electrocardiogram) recorder device over-the-counter (OTC) clearance. The company is now taking direct-to-consumer preorders for the device at a $199 pricepoint. It expects to begin shipping them in early March. Up until now the AliveCor device has only been made available to physicians and...